1. Ganassi, Massimo, Zammit, Peter S. 2022. Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies. In European journal of translational myology, 32, . doi:10.4081/ejtm.2022.10064. https://pubmed.ncbi.nlm.nih.gov/35302338/
2. Vaish, Vivek, Kim, Joohwee, Shim, Minsub. 2017. Jagged-2 (JAG2) enhances tumorigenicity and chemoresistance of colorectal cancer cells. In Oncotarget, 8, 53262-53275. doi:10.18632/oncotarget.18391. https://pubmed.ncbi.nlm.nih.gov/28881809/
3. Coppens, Sandra, Barnard, Alison M, Puusepp, Sanna, Walter, Glenn A, Kang, Peter B. 2021. A form of muscular dystrophy associated with pathogenic variants in JAG2. In American journal of human genetics, 108, 840-856. doi:10.1016/j.ajhg.2021.03.020. https://pubmed.ncbi.nlm.nih.gov/33861953/
4. Chen, Wujun, Wu, Xiaolin, Hu, Jianxia, Wang, Jie, Xing, Dongming. 2024. The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7. In Cardiovascular diabetology, 23, 21. doi:10.1186/s12933-024-02119-z. https://pubmed.ncbi.nlm.nih.gov/38195542/
5. Liu, Hanhan, Pan, Zhou, Wu, Xiaofeng, Gong, Cheng, Hu, Junbo. 2024. Jagged 2 inhibition attenuates hypoxia-induced mitochondrial damage and pulmonary hypertension through Sirtuin 1 signaling. In PloS one, 19, e0297525. doi:10.1371/journal.pone.0297525. https://pubmed.ncbi.nlm.nih.gov/38277398/